References
- Compton WM, Thomas YF, Conway KP, Colliver JD. Developments in the epidemiology of drug use and drug use disorders. Am J Psych 2005; 162: 1494–1502
- Bauman A, Phongsavan P. Epidemiology of substance use in adolescence: Prevalence, trends and policy implications. Drug Alcohol Depend 1999; 55: 187–207
- Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42: 64S–70S
- Jones RT. Cardiovascular effects of marijuana. J Clin Pharmacol 2002; 42: 58S–63S
- Ghalat PS, Kalra ML. Charas (cannabis) cardiomyopathy. J Indian Med Assoc 1985; 83: 158–159
- Macinnes DC, Miller KM. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract 1984; 34: 575–576
- Rezkalla SH, Sharma P, Cloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med 2003; 42: 365–367
- Mitteleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805–2809
- Lehavi A, Shay M, Gilony C, Even L. Marijuana smoking and paroxysmal atrial fibrillation. Harefuah 2005; 144: 2–3
- Short TG, Young Y. Toxicity of intravenous anaesthetics. Best Pract Res Clin Anaesthesiol 2003; 17: 77–89
- Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841–1845
- Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 2000; 23: 215–228
- Isner JM, Estes NA, III, Thompson PD, Costanza-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturmer WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438–1443